Better standards needed for industry sponsored clinical trialsBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7371.985/a (Published 02 November 2002) Cite this as: BMJ 2002;325:985
- Janice Hopkins Tanne
- New York
Three papers in the New England Journal of Medicine highlight problems of academic freedom and scientific integrity in agreements between medical schools and industry sponsors who pay for many clinical trials.
Agreements between industry and medical schools fall far short of the guidelines of the International Committee of Journal Editors and the Association of American …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial